Business Context and Reporting Period
Company: NeoGenomics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2026 (Event Date); January 12, 2026 (Filing Date)
Reporting Period: Preliminary results for the fourth quarter and fiscal year ended December 31, 2025.
Key Financial Metrics
This filing announces the issuance of a press release containing select preliminary unaudited financial results for Q4 and full-year 2025. However, the text of this 8-K does not disclose specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that these results are based on management estimates and are subject to material change.
Material Changes and Personnel Updates
- CFO Transition: Jeffrey S. Sherman, Chief Financial Officer, notified the Board of his intention to retire effective April 14, 2026.
- Interim Role: Mr. Sherman will transition to Executive Vice President, Finance effective March 2, 2026, serving until his retirement date. He will subsequently serve as a special advisor through April 2028.
- New Appointment: Abhishek Jain was appointed Executive Vice President, Finance effective January 12, 2026 (noted as 2025 in text, context implies 2026). He is scheduled to assume the role of Chief Financial Officer on March 2, 2026.
- Compensation: Mr. Jain's package includes a $520,000 annual base salary, a target bonus of 60% of salary, and an initial equity grant valued at $2,750,000 (split between RSUs and stock options).
Guidance, Outlook, and Risks
Unaudited Nature of Data: The preliminary financial results referenced in this filing have not been audited or reviewed by the Company's independent registered public accounting firm. The filing warns that such results are not comprehensive and may be subject to material changes.
Legal Status: Information furnished in Items 2.02 and 9.01 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section unless expressly incorporated by reference.
Investor Verification Checklist
- Verify the specific preliminary revenue and profit figures in the attached Press Release (Exhibit 99.1), as they are not listed in the 8-K text.
- Confirm the final audited financial results for the fiscal year ended December 31, 2025, once the audit is complete.
- Monitor the transition timeline for the CFO role, specifically the handover date of March 2, 2026.
- Review the Special Advisor Agreement to be entered into with Jeffrey S. Sherman regarding his post-retirement advisory role.